(Q74544908)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9586607%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

title

Percentage of free serum prostate-specific antigen as a predictor of pathologic features of prostate cancer in a screening population (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9586607%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

1 reference

Arcangeli CG

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9586607%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

Humphrey PA

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9586607%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

Smith DS

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9586607%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

Harmon TJ

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9586607%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

Shepherd DL

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9586607%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

Keetch DW

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9586607%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

Catalona WJ

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9586607%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

language of work or name

English

0 references

publication date

1 April 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9586607%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9586607%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

volume

51

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9586607%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9586607%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

page(s)

558-64; discussion 564-5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9586607%20AND%20SRC:MED&resulttype=core&format=json

Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: results of a multicenter clinical trial of 6,630 men.

11 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900035-1

7 January 2021

Serum concentrations of prostate specific antigen and its complex with alpha 1-antichymotrypsin before diagnosis of prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900035-1

7 January 2021

The value of screening tests in the detection of prostate cancer. Part I: Results of a retrospective evaluation of 1726 men.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900035-1

7 January 2021

Measurement of the proportion of free to total prostate-specific antigen improves diagnostic performance of prostate-specific antigen in the diagnostic gray zone of total prostate-specific antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900035-1

7 January 2021

Prostate cancer detection in men with serum PSA concentrations of 2.6 to 4.0 ng/mL and benign prostate examination. Enhancement of specificity with free PSA measurements

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900035-1

7 January 2021

The Nature of Prostate Cancer Detected Through Prostate Specific Antigen Based Screening

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900035-1

7 January 2021

Prospective characterization of pathological features of prostatic carcinomas detected via serum prostate specific antigen based screening

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900035-1

7 January 2021

Measurement of Prostate-Specific Antigen in Serum as a Screening Test for Prostate Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900035-1

7 January 2021

Determination of prostate volume by transrectal ultrasound

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900035-1

7 January 2021

Histologic grading of prostate cancer: a perspective

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900035-1

7 January 2021

Intraglandular tumor extent and prognosis in prostatic carcinoma: application of a grid method to prostatectomy specimens.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900035-1

7 January 2021

The Pathological Features and Prognosis of Prostate Cancer Detectable With Current Diagnostic Tests

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900035-1

7 January 2021

Stratification of pathologic features in radical prostatectomy specimens that are predictive of elevated initial postoperative serum prostate-specific antigen levels

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900035-1

7 January 2021

Impalpable invisible stage T1c prostate cancer: characteristics and clinical relevance in 100 radical prostatectomy specimens--a different view

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900035-1

7 January 2021

Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900035-1

7 January 2021

Prediction of progression following radical prostatectomy. A multivariate analysis of 721 men with long-term follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900035-1

7 January 2021

Percentage of free prostate-specific antigen in sera predicts aggressiveness of prostate cancer a decade before diagnosis

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900035-1

7 January 2021

The role of free/total prostate-specific antigen ratio in the prediction of final pathologic stage for men with clinically localized prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900035-1

7 January 2021

The free-to-total serum prostate specific antigen ratio for staging prostate carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900035-1

7 January 2021

Biological variation of total, free and percent free serum prostate specific antigen levels in screening volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900035-1

7 January 2021

Incidence of prostate cancer diagnosis in the eras before and after serum prostate-specific antigen testing

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900035-1

7 January 2021

10.1016/S0090-4295(98)00035-1

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9586607%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

1 reference